Daré Bioscience, Inc.

DARE · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$15,698$10,476$34,670$51,674
Short-Term Investments$0$0$0$0
Receivables$230$949$1,703$1,145
Inventory$0$0$0$0
Other Curr. Assets$0$0$0$0
Total Curr. Assets$18,448$17,544$43,039$55,296
Property Plant & Equip (Net)$2,543$1,976$523$243
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$335$0$0
Tax Assets$0$0$0$0
Other NC Assets$1,111$1,428$265$268
Total NC Assets$3,653$3,739$788$511
Other Assets$0$0$0$0
Total Assets$22,101$21,282$43,826$55,807
Liabilities
Payables$1,456$3,386$2,028$2,103
Short-Term Debt$0$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$16,562$13,737$18,304$10,543
Other Curr. Liab.$806$2,084$1,721$1,533
Total Curr. Liab.$21,609$20,480$31,624$16,053
LT Debt$0$0$0$0
Deferred Rev, NC$1,000$1,000$1,000$1,000
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$4,750$3,914$0$0
Total NC Liab.$6,504$5,849$1,090$1,000
Other Liabilities$0$0$0$0
Cap. Leases$1,303$1,404$489$271
Total Liabilities$28,113$26,330$32,714$17,053
Equity
Pref Stock$0$0$0$0
Common Stock$1$10$8$8
Retained Earnings-$175,290-$171,236-$141,075-$110,127
AOCI-$429-$361-$351-$155
Other Equity$0$0$0$0
Total Equity-$6,012-$5,048$11,112$38,754
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$22,101$21,282$43,826$55,807
Net Debt-$15,698-$10,476-$34,670-$51,674